Detection of SARS-CoV-2 Antibodies in Immunoglobulin Products

BACKGROUND: For patients with primary antibody deficiency, the first line of therapy is replacement with immunoglobulin (Ig) products. Prior to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, Ig products did not contain antibodies with specificity for this virus, and there...

Descripción completa

Detalles Bibliográficos
Autores principales: Cousins, Kimberley, Sano, Kaori, Lam, Brandon, Röltgen, Katharina, Bhavsar, Disha, Singh, Gagandeep, McRae, Oliver, Jeong, Stephanie, Aboelregal, Nouran, Ho, Hsi-en, Boyd, Scott, Krammer, Florian, Cunningham-Rundles, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176888/
https://www.ncbi.nlm.nih.gov/pubmed/37182564
http://dx.doi.org/10.1016/j.jaip.2023.05.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176888/
https://www.ncbi.nlm.nih.gov/pubmed/37182564
http://dx.doi.org/10.1016/j.jaip.2023.05.005

Ejemplares similares